HK2482A - 3-acyloxymethyl-cephem compounds - Google Patents

3-acyloxymethyl-cephem compounds

Info

Publication number
HK2482A
HK2482A HK24/82A HK2482A HK2482A HK 2482 A HK2482 A HK 2482A HK 24/82 A HK24/82 A HK 24/82A HK 2482 A HK2482 A HK 2482A HK 2482 A HK2482 A HK 2482A
Authority
HK
Hong Kong
Prior art keywords
acyloxymethyl
cephem compounds
cephem
compounds
Prior art date
Application number
HK24/82A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2315875A external-priority patent/JPS5837316B2/ja
Priority claimed from JP3375975A external-priority patent/JPS5951553B2/ja
Priority claimed from JP3471475A external-priority patent/JPS5951554B2/ja
Priority claimed from JP127476A external-priority patent/JPS5283869A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of HK2482A publication Critical patent/HK2482A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
HK24/82A 1975-02-24 1982-02-14 3-acyloxymethyl-cephem compounds HK2482A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2315875A JPS5837316B2 (ja) 1975-02-24 1975-02-24 セフアロスポリンカゴウブツノ セイゾウホウ
JP3375975A JPS5951553B2 (ja) 1975-03-20 1975-03-20 セフアロスポリン化合物の製造法
JP3471475A JPS5951554B2 (ja) 1975-03-21 1975-03-21 セフアロスポリン化合物の製造法
JP127476A JPS5283869A (en) 1976-01-01 1976-01-01 Cephalosporin compounds

Publications (1)

Publication Number Publication Date
HK2482A true HK2482A (en) 1982-02-14

Family

ID=27453366

Family Applications (1)

Application Number Title Priority Date Filing Date
HK24/82A HK2482A (en) 1975-02-24 1982-02-14 3-acyloxymethyl-cephem compounds

Country Status (18)

Country Link
US (1) US4245088A (sv)
AT (1) AT346486B (sv)
AU (1) AU496914B2 (sv)
BE (1) BE838833A (sv)
CA (1) CA1092095A (sv)
CH (1) CH625245A5 (sv)
DE (1) DE2607064C2 (sv)
DK (3) DK159154C (sv)
ES (2) ES445348A1 (sv)
FR (1) FR2301528A1 (sv)
GB (1) GB1544103A (sv)
HK (1) HK2482A (sv)
HU (2) HU179598B (sv)
MX (1) MX3635E (sv)
NL (1) NL187166C (sv)
NO (1) NO760590L (sv)
PH (1) PH16245A (sv)
SE (2) SE435182B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323676A (en) * 1975-02-24 1982-04-06 Takeda Chemical Industries, Ltd. Process for preparing cephalosporins
BE878433A (fr) * 1978-08-31 1980-02-25 Fujisawa Pharmaceutical Co Procede de preparation de derives d'acide 3-cephem-4-carboxylique 3,7-disubstitue, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
GR70261B (sv) * 1977-12-12 1982-09-02 Takeda Chemical Industries Ltd
ZA825095B (en) * 1981-07-17 1983-05-25 Glaxo Group Ltd Cephalosporin compounds
US4584371A (en) * 1984-03-01 1986-04-22 The Upjohn Company Catalytic process for preparing 3-ester-methyl cephalosporins from desacetyl-7-aminocephalosporanic acid
JP2867438B2 (ja) * 1988-08-10 1999-03-08 武田薬品工業株式会社 セファロスポリン化合物の製造法
US5552542A (en) * 1995-05-10 1996-09-03 Bristol-Myers Squibb Company Preparation and use of 7-[(2-carboalkoxy-1-methylethenyl)amino]-3-hydroxymethyl-3-cephem-4-carboxylic acids
US8198434B2 (en) * 2008-05-07 2012-06-12 Idexx Laboratories, Inc. Process for preparing cefsulodin sodium
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
EP3426663B1 (en) * 2016-03-07 2020-01-29 Dhanuka Laboratories Ltd. A process for alkylating the hydroxymethyl group at position -3 of cephalosporins
NL2022854B1 (en) * 2019-04-03 2020-10-08 Univ Leiden Prodrug inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241657A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds
US4007178A (en) * 1972-04-10 1977-02-08 Smithkline Corporation O-acyl-7-acylaminocephalosporadesic acids

Also Published As

Publication number Publication date
DK63990D0 (da) 1990-03-12
US4245088A (en) 1981-01-13
DK160313B (da) 1991-02-25
DK44076A (da) 1976-08-25
DK76190D0 (da) 1990-03-23
NO760590L (sv) 1976-08-25
AU496914B2 (en) 1978-11-09
ES459261A1 (es) 1978-03-16
ATA126476A (de) 1978-03-15
AU1134976A (en) 1977-09-01
DE2607064C2 (de) 1984-12-13
ES445348A1 (es) 1977-10-16
SE435183B (sv) 1984-09-10
NL187166C (nl) 1991-06-17
DK159154C (da) 1991-02-11
DK159154B (da) 1990-09-10
HU179598B (en) 1982-11-29
AT346486B (de) 1978-11-10
MX3635E (es) 1981-04-13
HU179070B (en) 1982-08-28
DK160313C (da) 1991-07-29
FR2301528B1 (sv) 1979-04-20
SE7907455L (sv) 1979-09-07
PH16245A (en) 1983-08-16
GB1544103A (en) 1979-04-11
DK63990A (da) 1990-03-12
DK161201C (da) 1991-11-25
SE7907454L (sv) 1979-09-07
SE435182B (sv) 1984-09-10
BE838833A (fr) 1976-08-23
NL7601902A (nl) 1976-08-26
DE2607064A1 (de) 1976-09-02
FR2301528A1 (fr) 1976-09-17
DK76190A (da) 1990-03-23
CH625245A5 (sv) 1981-09-15
CA1092095A (en) 1980-12-23
DK161201B (da) 1991-06-10

Similar Documents

Publication Publication Date Title
GB1539006A (en) Aminoalkylammonium compound
JPS57112388A (en) 1-sulfonylbenzimidazole compound
JPS51113900A (en) Riphamycin compound
JPS5268104A (en) Symmetric bisscarbamate compounds
GB1557482A (en) Substituted tetranorprostaglandins
GB1544103A (en) 3-acyloxymethyl-cephem compounds
ZA764267B (en) Sulphine compounds
JPS5223076A (en) Antiiinflammatory compound
JPS51143699A (en) Riphamycin compound
JPS51115450A (en) Phosphorrcontaining compounds
JPS5236665A (en) 44dithioo33imide azethizinee 22one compound
JPS5231062A (en) Perfluoroalkylthionorbornane compound
JPS5231095A (en) Cephlosporin type compound
ZM576A1 (en) Compounds
JPS5285106A (en) Carbamateesulphenyllcarbamoylfluoride compounds
JPS5278869A (en) Thienylpolyene compound
AU1735076A (en) Substituted sulfoximides
JPS5265276A (en) Substituted tetraalkylpiperidinee44oxime
ZA762999B (en) Novel diureide compounds
JPS5271454A (en) Compound
GB1518029A (en) Substituted aminoalkylaminopyridine compounds
JPS5227784A (en) Phenylsulfenylpiperazine compound
GB1551785A (en) 7-amino-acylamino-3-halo-cephem compounds
JPS51106374A (en) Sharyoyotogu no juhyojusetsusochi
JPS5273893A (en) Betaalactummcontaining compounds